Hydroxychalcones induce apoptosis in B16-F10 melanoma cells via GSH and ATP depletion

被引:52
作者
Formento Navarini, Andreia Lilian [1 ]
Chiaradia, Louise Domeneghini [2 ]
Mascarello, Alessandra [2 ]
Fritzen, Marcio [1 ]
Nunes, Ricardo Jose [2 ]
Yunes, Rosendo Augusto [2 ]
Creczynski-Pasa, Tania Beatriz [1 ]
机构
[1] Univ Fed Santa Catarina, Ctr Ciencias Saude, Dept Ciencias Farmaceut, BR-88040900 Florianopolis, SC, Brazil
[2] Univ Fed Santa Catarina, Dept Quim, BR-88040900 Florianopolis, SC, Brazil
关键词
Hydroxychalcones; Melanoma; Antitumoral; Apoptosis; GSH; ATP; MALIGNANT-MELANOMA; 4A5; CELLS; G2; CHALCONES; CANCER; GROWTH; AGENTS; ISOLIQUIRITIGENIN; HETEROGENEITY; CYTOTOXICITY;
D O I
10.1016/j.ejmech.2008.09.009
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Searching for leading compounds of new drugs for cancer therapy, we studied the toxicity of 13 hydroxychalcones never tested before toward melanoma cell line (B16-F10). The compounds were obtained by aldolic condensation between aldehydes and hydroxylated acetophenones, in alkaline conditions. Three of them showed cytotoxicity to the cell line. Two of them induced mitochondrial GSH and ATP depletion and promoted cell death through apoptosis in melanoma cells. One of the compounds induced cell death through necrosis but did not significantly decrease the intracellular mitochondrial GSH and ATP levels in melanoma cells. The results suggest that the predominant factor for the activity is the molecule shape, and secondarily the number of hydroxyl groups. (c) 2008 Published by Elsevier Masson SAS.
引用
收藏
页码:1630 / 1637
页数:8
相关论文
共 40 条
[1]  
[Anonymous], NATURAL PRODUCT CHEM
[2]   Fotemustine compared with dacarbazine in patients with disseminated malignant melanoma:: A phase III study [J].
Avril, MF ;
Aamdal, S ;
Grob, JJ ;
Hauschild, A ;
Mohr, P ;
Bonerandi, JJ ;
Weichenthal, M ;
Neuber, K ;
Bieber, T ;
Gilde, K ;
Porta, VG ;
Fra, J ;
Bonneterre, J ;
Saïag, P ;
Kamanabrou, D ;
Pehamberger, H ;
Sufliarsky, J ;
Larriba, JLG ;
Scherrer, A ;
Menu, Y .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (06) :1118-1125
[3]   Synthesis of chalcone analogues with increased antileishmanial activity [J].
Boeck, P ;
Falcao, CAB ;
Leal, PC ;
Yunes, RA ;
Cechinel, V ;
Torres-Santos, EC ;
Rossi-Bergmann, B .
BIOORGANIC & MEDICINAL CHEMISTRY, 2006, 14 (05) :1538-1545
[4]   Regioselective bromination of organic substrates by tetrabutylammonium bromide promoted by V2O5-H2O2:: An environmentally favorable synthetic protocol [J].
Bora, U ;
Bose, G ;
Chaudhuri, MK ;
Dhar, SS ;
Gopinath, R ;
Khan, AT ;
Patel, BK .
ORGANIC LETTERS, 2000, 2 (03) :247-249
[5]   Synthetic chalcones, flavanones, and flavones as antitumoral agents:: Biological evaluation and structure-activity relationships [J].
Cabrera, Mauricio ;
Simoens, Macarena ;
Falchi, Gabriela ;
Lavaggi, M. Laura ;
Piro, Oscar E. ;
Castellano, Eduardo E. ;
Vidal, Anabel ;
Azqueta, Amaia ;
Monge, Antonio ;
de Cerain, Adela Lopez ;
Sagrera, Gabriel ;
Scoane, Gustavo ;
Cerecetto, Hugo ;
Gonzalez, Mercedes .
BIOORGANIC & MEDICINAL CHEMISTRY, 2007, 15 (10) :3356-3367
[6]   Curcurnin induces apoptosis through mitochondrial hyperpolarization and mtDNA damage in human hepatoma G2 cells [J].
Cao, Jun ;
Liu, Yong ;
Jia, Li ;
Zhou, Hui-Min ;
Kong, Ying ;
Yang, Guang ;
Jiang, Li-Ping ;
Li, Qiu-Juan ;
Zhong, Lai-Fu .
FREE RADICAL BIOLOGY AND MEDICINE, 2007, 43 (06) :968-975
[7]   Synthesis of xanthoxyline derivatives with antinociceptive and antioedematogenic activities [J].
Cechinel, V ;
Vaz, ZR ;
Zunino, L ;
Calixto, JB ;
Yunes, RA .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1996, 31 (10) :833-839
[8]   Cytotoxicity and lipid peroxidation-inhibiting activity of flavonoids [J].
Cos, P ;
Calomme, M ;
Sindambiwe, JB ;
De Bruyne, T ;
Cimanga, K ;
Pieters, L ;
Vlietinck, AJ ;
Vanden Berghe, D .
PLANTA MEDICA, 2001, 67 (06) :515-519
[9]   In vitro antioxidant profile of phenolic acid derivatives [J].
Cos, P ;
Rajan, P ;
Vedernikova, I ;
Calomme, M ;
Pieters, L ;
Vlietinck, AJ ;
Augustyns, K ;
Haemers, A ;
Vanden Berghe, D .
FREE RADICAL RESEARCH, 2002, 36 (06) :711-716
[10]   Drugs targeting mitochondrial functions to control tumor cell growth [J].
Dias, N ;
Bailly, C .
BIOCHEMICAL PHARMACOLOGY, 2005, 70 (01) :1-12